New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
Population aging is predicted to be the primary contributor to the estimated 112% surge in global Parkinson's disease cases by 2050, a BMJ study finds.
New research emphasizes early detection of underlying neurologic conditions can improve outcomes for patients presenting with lower urinary tract symptoms
February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.
New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.